Doximity (DOCS) Competitors $72.25 -2.75 (-3.67%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$71.50 -0.75 (-1.04%) As of 02/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends DOCS vs. XYZ, DDOG, HUBS, RBLX, TTD, WIT, VEEV, BIDU, EA, and IOTShould you be buying Doximity stock or one of its competitors? The main competitors of Doximity include Block (XYZ), Datadog (DDOG), HubSpot (HUBS), Roblox (RBLX), Trade Desk (TTD), Wipro (WIT), Veeva Systems (VEEV), Baidu (BIDU), Electronic Arts (EA), and Samsara (IOT). These companies are all part of the "computer software" industry. Doximity vs. Block Datadog HubSpot Roblox Trade Desk Wipro Veeva Systems Baidu Electronic Arts Samsara Doximity (NASDAQ:DOCS) and (:) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk, community ranking and valuation. Does the media favor DOCS or ? In the previous week, had 2133 more articles in the media than Doximity. MarketBeat recorded 2143 mentions for and 10 mentions for Doximity. Doximity's average media sentiment score of 1.37 beat 's score of 0.00 indicating that Doximity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 10 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 746 Very Positive mention(s) 380 Positive mention(s) 521 Neutral mention(s) 281 Negative mention(s) 215 Very Negative mention(s) Neutral Do analysts recommend DOCS or ? Doximity presently has a consensus price target of $64.22, suggesting a potential downside of 11.11%. Given 's higher possible upside, analysts clearly believe is more favorable than Doximity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Doximity 0 Sell rating(s) 11 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 2.57 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better valuation & earnings, DOCS or ? Doximity has higher revenue and earnings than . CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDoximity$475.42M28.37$147.58M$1.0072.25N/AN/AN/AN/AN/A Do institutionals & insiders hold more shares of DOCS or ? 87.2% of Doximity shares are held by institutional investors. 37.4% of Doximity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is DOCS or more profitable? Doximity has a net margin of 36.60% compared to 's net margin of 0.00%. Doximity's return on equity of 21.75% beat 's return on equity.Company Net Margins Return on Equity Return on Assets Doximity36.60% 21.75% 18.64% N/A N/A N/A Does the MarketBeat Community favor DOCS or ? Doximity received 64 more outperform votes than when rated by MarketBeat users. CompanyUnderperformOutperformDoximityOutperform Votes6440.00% Underperform Votes9660.00% N/AN/A SummaryDoximity beats on 11 of the 13 factors compared between the two stocks. Get Doximity News Delivered to You Automatically Sign up to receive the latest news and ratings for DOCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DOCS vs. The Competition Export to ExcelMetricDoximityCustom computer programming services IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.00B$7.73B$5.84B$9.14BDividend YieldN/A2.60%4.76%3.85%P/E Ratio72.8285.1218.2614.95Price / Sales28.3717.70434.4770.76Price / Cash81.3223.7738.4235.17Price / Book13.096.167.644.65Net Income$147.58M$204.55M$3.18B$245.69M7 Day Performance-6.32%9.09%-1.95%-2.68%1 Month Performance29.02%2.43%-0.23%-2.16%1 Year Performance149.06%30.99%16.69%12.90% Doximity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DOCSDoximity2.5822 of 5 stars$72.25-3.7%$64.22-11.1%+149.0%$14.00B$475.42M72.82890Positive NewsXYZBlock4.7989 of 5 stars$83.98-0.4%N/AN/A$52.05B$21.92B47.1812,985Earnings ReportAnalyst ForecastDDOGDatadog4.9521 of 5 stars$131.01-3.6%$158.39+20.9%-4.9%$44.51B$2.13B247.195,200Analyst DowngradeHigh Trading VolumeHUBSHubSpot4.6644 of 5 stars$812.44-0.9%$863.96+6.3%+23.3%$41.94B$2.17B-3,008.927,663Analyst ForecastInsider TradeRBLXRoblox2.7622 of 5 stars$66.62+1.7%$64.19-3.6%+53.4%$40.48B$3.60B-45.952,457Insider TradeTTDTrade Desk4.2032 of 5 stars$80.16-2.1%$120.97+50.9%-12.2%$39.56B$1.95B131.413,115Analyst ForecastBuyback AnnouncementOptions VolumeNews CoverageHigh Trading VolumeWITWipro2.0531 of 5 stars$3.64+0.1%N/A-43.5%$38.01B$10.77B25.07234,054Positive NewsVEEVVeeva Systems4.2308 of 5 stars$234.090.0%$253.96+8.5%+4.5%$38.00B$2.36B57.807,172Positive NewsBIDUBaidu4.7756 of 5 stars$97.48+0.9%$112.08+15.0%-15.0%$34.18B$18.96B11.9339,800Upcoming EarningsAnalyst ForecastGap UpHigh Trading VolumeEAElectronic Arts4.7042 of 5 stars$129.40-0.3%$155.24+20.0%-7.3%$33.72B$7.56B32.9313,700Analyst UpgradeInsider TradeAnalyst RevisionIOTSamsara2.2016 of 5 stars$58.98+4.6%$51.67-12.4%+67.1%$33.10B$1.18B-125.482,895 Related Companies and Tools Related Companies XYZ Alternatives DDOG Alternatives HUBS Alternatives RBLX Alternatives TTD Alternatives WIT Alternatives VEEV Alternatives BIDU Alternatives EA Alternatives IOT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DOCS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DOCS Stock Alerts